For example, chronic duloxetine administration increases PFC BDNF mRNA and protein levels in animal models for depression, correlating with an improvement in emotional behaviors (Calabrese et al., 2007; Mannari et al., 2008; Engel et al., 2013). Here, BDNF is linked to depressive symptom measurement.